One of the fundamental barriers to equitable neurological care is the historic male bias in clinical research. For decades, ...

Upcoming FDA meeting During the second half of 2025, the Actinogen clinical, nonclinical, manufacturing and regulatory teams will meet with the US FDA to discuss the detailed potential pathways to FDA ...

Alzheimer’s disease (AD) is a prevalent neurodegenerative disorder marked primarily by β-amyloid (Aβ) deposition and abnormal ...

Interim analysis planned for January 2026 with final trial results in late 2026 Highlights: With the 100th participant enrolled in the XanaMIA trial, the timeline ...

Tens of thousands of people suffer needless heart attacks and strokes every year because they aren't taking ...

A recent population-based study published in the Journal of American Medical Association identified a modest increase in ...

The study, carried out by experts from the University of Nottingham, found that there was nearly a 50% increased risk of ...

Federal programs that support people with brain injury, such as HEADS UP and the National Concussion Surveillance System, are ...

The portrayal of uncaring scientists without any thought for the animals being used in their research is far from the truth.

It includes dementia with Lewy bodies and Parkinson’s disease, with or without dementia. While often overshadowed by Alzheimer’s, it's the second most common neurodegenerative disease worldwide. The ...

Weeks after President Donald Trump took office, multiple government webpages referencing gender and sexual orientation ...

Despite their technical brilliance, existing machine learning (ML) and LLM-based systems struggle in real-world healthcare ...